Axsome Therapeutics, Inc. (AXSM) stock
AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$134.00−1.95 (-1.43%)
Close on Nov 18, 2026Market cap $7.02BP/E –Yield –
Axsome Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Axsome Therapeutics's price to sales ratio was 10.1× on Nov 11, 2026, against 13.6× a year earlier. Over the last 4 years it ranged from 9.7× to 62.2×, with a median of 14.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.1× | −6.3 |
| 2025 | Dec 31, 2025 | 16.4× | +4.3 |
| 2024 | Dec 31, 2024 | 12.1× | −4.7 |
| 2023 | Dec 29, 2023 | 16.9× | – |
See a number that looks wrong?